RT Journal Article
SR Electronic
T1 <em>TYRO3</em> Knockdown Suppresses the Growth of Myeloid Leukaemia Cells
JF Anticancer Research
JO Anticancer Res
FD International Institute of Anticancer Research
SP 1757
OP 1761
DO 10.21873/anticanres.15652
VO 42
IS 4
A1 SAITO, TATSUYA
A1 ITOH, MAI
A1 TOHDA, SHUJI
YR 2022
UL http://ar.iiarjournals.org/content/42/4/1757.abstract
AB Background/Aim: TYRO3 is a member of the TAM family (TYRO3, AXL, and MERTK) of receptor tyrosine kinases. While the roles of activated AXL and MERTK in the growth of leukaemia cells have been reported, the effect of TYRO3 has not been determined. Therefore, we examined the effects of TYRO3 knockdown on the growth of leukaemia cell lines. Materials and Methods: Three human leukaemia cell lines (AA derived from pure erythroid leukaemia, OCI/AML2, and K562), which express TYRO3 protein were used in this study. To induce TYRO3 knockdown, small interfering RNA (siRNA) against TYRO3 was transfected using an electroporation system. Cell growth was assessed by a colorimetric assay. The expression levels and activation of various signalling proteins were examined by immunoblotting. Changes in comprehensive gene expression after TYRO3 knockdown were examined by microarray analysis. Results: TYRO3 knockdown suppressed cell growth in the leukaemia cell lines tested. Additionally, the knockdown suppressed phosphorylation of signal transducer and activator of transcription-3 in AA cells, and extracellular signal-regulated kinase (ERK) 1/2 in AA and OCI/AML2 cells; both are downstream molecules of TYRO3 signalling. TYRO3 knockdown also suppressed the expression of survivin in all the cell lines. TYRO3 knockdown potently suppressed TYRO3 mRNA expression but not that of AXL and MERTK. Furthermore, TYRO3 knockdown suppressed cyclin D1 mRNA expression, which is a downstream molecule of ERK. Conclusion: TYRO3 plays a role in leukaemia cell growth and is a potential therapeutic target for leukaemia.